BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seiler K, Soroush Noghabi M, Karjalainen K, Hummel M, Melchers F, Tsuneto M. Induced Pluripotent Stem Cells Expressing Elevated Levels of Sox-2, Oct-4, and Klf-4 Are Severely Reduced in Their Differentiation from Mesodermal to Hematopoietic Progenitor Cells. Stem Cells and Development 2011;20:1131-42. [DOI: 10.1089/scd.2010.0391] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsuneto M, Kajikhina E, Seiler K, Reimer A, Tornack J, Bouquet C, Simmons S, Knoll M, Wolf I, Tokoyoda K, Hauser A, Hara T, Tani-ichi S, Ikuta K, Grün JR, Grützkau A, Engels N, Wienands J, Yanagisawa Y, Ohnishi K, Melchers F. Reprint of: Environments of B cell development. Immunol Lett 2014;160:109-12. [PMID: 24852107 DOI: 10.1016/j.imlet.2014.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Hu K, Slukvin I. Induction of Pluripotent Stem Cells from Umbilical Cord Blood. In: Meyers RA, editor. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2006. [DOI: 10.1002/3527600906.mcb.201200006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Wilson R, Urraca N, Skobowiat C, Hope KA, Miravalle L, Chamberlin R, Donaldson M, Seagroves TN, Reiter LT. Assessment of the Tumorigenic Potential of Spontaneously Immortalized and hTERT-Immortalized Cultured Dental Pulp Stem Cells. Stem Cells Transl Med. 2015;4:905-912. [PMID: 26032749 DOI: 10.5966/sctm.2014-0196] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
4 Zhang XB. Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics 2013;11:264-74. [PMID: 24060839 DOI: 10.1016/j.gpb.2013.09.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
5 Tsuneto M, Kajikhina E, Seiler K, Reimer A, Tornack J, Bouquet C, Simmons S, Knoll M, Wolf I, Tokoyoda K, Hauser A, Hara T, Tani-ichi S, Ikuta K, Grün JR, Grützkau A, Engels N, Wienands J, Yanagisawa Y, Ohnishi K, Melchers F. Environments of B cell development. Immunol Lett 2014;157:60-3. [PMID: 24284375 DOI: 10.1016/j.imlet.2013.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Reimer A, Seiler K, Tornack J, Tsuneto M, Melchers F. Reprogramming to iPS cells and their subsequent hematopoietic differentiation is more efficient from MEFs than from preB cells. Immunol Lett 2012;143:70-6. [PMID: 22313949 DOI: 10.1016/j.imlet.2012.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Xu Y, Liu L, Zhang L, Fu S, Hu Y, Wang Y, Fu H, Wu K, Xiao H, Liu S, Yu X, Zheng W, Feng B, Huang H. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells. PLoS One 2012;7:e34321. [PMID: 22496789 DOI: 10.1371/journal.pone.0034321] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
8 Bialkowska AB, Yang VW, Mallipattu SK. Krüppel-like factors in mammalian stem cells and development. Development 2017;144:737-54. [PMID: 28246209 DOI: 10.1242/dev.145441] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 13.8] [Reference Citation Analysis]
9 Liu S, Xu Y, Zhou Z, Feng B, Huang H. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells. Cytotherapy 2015;17:344-58. [PMID: 25680303 DOI: 10.1016/j.jcyt.2015.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
10 Krueger WH, Tanasijevic B, Norris C, Tian XC, Rasmussen TP. Oct4 promoter activity in stem cells obtained through somatic reprogramming. Cell Reprogram 2013;15:151-8. [PMID: 23550731 DOI: 10.1089/cell.2012.0059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Tornack J, Seiler K, Grützkau A, Grün JR, Onodera M, Melchers F, Tsuneto M. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis. PLoS One 2013;8:e70116. [PMID: 23922928 DOI: 10.1371/journal.pone.0070116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Miyanishi M, Mori Y, Seita J, Chen JY, Karten S, Chan CK, Nakauchi H, Weissman IL. Do pluripotent stem cells exist in adult mice as very small embryonic stem cells? Stem Cell Reports. 2013;1:198-208. [PMID: 24052953 DOI: 10.1016/j.stemcr.2013.07.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 8.1] [Reference Citation Analysis]
13 Cao Y, Wang X, Tang L, Li Y, Song X, Liu X, Li M, Chen F, Wan H. Engrailed-2 promotes a malignant phenotype of esophageal squamous cell carcinoma through upregulating the expression of pro-oncogenic genes. PeerJ 2020;8:e8662. [PMID: 32117645 DOI: 10.7717/peerj.8662] [Reference Citation Analysis]
14 Morshedi A, Ren Z, Li J, Dröge P. Probing into the biological processes influenced by ESC factor and oncoprotein HMGA2 using iPSCs. Stem Cell Rev Rep 2013;9:514-22. [PMID: 22547345 DOI: 10.1007/s12015-012-9373-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
15 Wan Safwani WK, Makpol S, Sathapan S, Chua KH. 5-Azacytidine is insufficient for cardiogenesis in human adipose-derived stem cells. J Negat Results Biomed 2012;11:3. [PMID: 22221649 DOI: 10.1186/1477-5751-11-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
16 Morshedi A, Soroush Noghabi M, Dröge P. Use of UTF1 genetic control elements as iPSC reporter. Stem Cell Rev Rep 2013;9:523-30. [PMID: 22205530 DOI: 10.1007/s12015-011-9342-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
17 Seiler K, Tsuneto M, Melchers F. Experimental limitations using reprogrammed cells for hematopoietic differentiation. J Biomed Biotechnol 2011;2011:895086. [PMID: 22187531 DOI: 10.1155/2011/895086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Flamant S, Chomel JC, Desterke C, Féraud O, Gobbo E, Mitjavila-Garcia MT, Foudi A, Griscelli F, Turhan AG, Bennaceur-Griscelli A. Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells. Int J Mol Sci 2019;20:E1737. [PMID: 30965622 DOI: 10.3390/ijms20071737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Chen U. Do we have a workable clinical protocol for differentiating lympho-hematopoietic stem cells from the source of embryonic stem cells and induced pluripotent stem cells in culture? Scand J Immunol 2014;80:247-9. [PMID: 25041639 DOI: 10.1111/sji.12210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Shen G, Hu Y, Wu J, Jin K, Zhu D, Zhang Y, Yu Y, Lou Y. A 2,6-Disubstituted 4-Anilinoquinazoline Derivative Facilitates Cardiomyogenesis of Embryonic Stem Cells. ChemMedChem 2012;7:733-40. [DOI: 10.1002/cmdc.201100603] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Wong CK, So WY, Law SK, Leung FP, Yau KL, Yao X, Huang Y, Li X, Tsang SY. Estrogen controls embryonic stem cell proliferation via store-operated calcium entry and the nuclear factor of activated T-cells (NFAT). J Cell Physiol. 2012;227:2519-2530. [PMID: 21898397 DOI: 10.1002/jcp.22990] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]